FABPulous logo

FABPulous

Developing ultra-rapid diagnostics for primary care and emergency medicine.

est. 2000

VS
Maven Biotechnologies logo

Maven Biotechnologies

Transforming respiratory, infectious, and autoimmune disease with Point of Care diagnostics.

1 employees · est. 2000

Side-by-Side Comparison

FABPulous Maven Biotechnologies
Founded
2000 2000
Headquarters
Not tracked yet Not tracked yet
Employees
Not tracked yet 1
Industry
Biotechnology, Care Economy, Health Care Big Data, Biotechnology, Health Care
Funding Stage
Series Unknown Grant
Total Funding
$3.43M $1.96M
Funding Rounds
4 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Medical Diagnostics, Point-of-Care Testing, Emergency Medicine, Primary Care, Rapid Diagnostics, Cardiac Biomarkers, Medical Technology, Startup, Investment, Biotech, Netherlands, Maastricht University, Equity Financing, Health Innovations Point Of Care Diagnostics, In-Vitro Diagnostic Systems, Respiratory Diseases, Infectious Diseases, Autoimmune Diseases, Antibody Biomarkers, Protein Biomarkers, Diagnostic Panels, Medical Diagnostics, Medical Devices, Healthcare Innovation, Blood Testing, Healthcare Technology Start-up
Website
fabpulous.com mavenbiotech.com
FABPulous logo

About FABPulous

FABPulous is a pioneering healthcare company based in The Netherlands, established in 2008 as a spinoff from Maastricht University. The company secured its initial equity financing in December 2009 with key investors including Thuja Capital, Health Innovations, Limburg Ventures, and NV Industriebank...

Maven Biotechnologies logo

About Maven Biotechnologies

Maven Biotechnologies is a biotechnology startup founded in 2000 with a focus on transforming respiratory, infectious, and autoimmune disease with Point of Care diagnostics. The company's In-Vitro Diagnostic systems bring respiratory, infectious disease, and autoimmune diagnostic panels to Point of...

We will tell you when either one moves

BounceWatch watches FABPulous and Maven Biotechnologies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at FABPulous and Maven Biotechnologies — by email.

Frequently Asked Questions

FABPulous — Developing ultra-rapid diagnostics for primary care and emergency medicine.. Maven Biotechnologies — Transforming respiratory, infectious, and autoimmune disease with Point of Care diagnostics.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
FABPulous has raised $3.43M while Maven Biotechnologies has raised $1.96M.
FABPulous and Maven Biotechnologies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare FABPulous with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at FABPulous on 12 Sep 2024, and Maven Biotechnologies on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes